ANAB · Anaptysbio, Inc · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-15 | Schmid John P. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
Common Stock
|
6,030 |
| 2026-06-15 | Schmid John P. |
Director |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Restricted Stock Unit
|
6,030 |
| 2026-06-15 | RENTON HOLLINGS |
Director |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Restricted Stock Unit
|
6,030 |
| 2026-06-15 | Orwin John A |
Director |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Restricted Stock Unit
|
6,030 |
| 2026-06-15 | Orwin John A |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
Common Stock
|
6,030 |
| 2026-06-15 | RENTON HOLLINGS |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
Common Stock
|
6,030 |
| 2026-05-11 | Murphy Christopher M. |
Chief Financial Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The RSUs vests as to 25% of the total RSUs annually commencing on May 11, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Restricted Stock Units
|
25,765 |
| 2026-05-11 | Hughes Owen |
Director, President and CEO |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. 1/3 of the RSUs shall vest on May 11, 2027 and 1/3 of the RSUs shall vest in equal annual installments until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Restricted Stock Units
|
11,250 |
| 2026-04-27 | GRAY SUSANNAH |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. 1/3 of the RSUs shall vest on April 27, 2027 and 1/3 of the RSUs shall vest in equal annual installments until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Restricted Stock Unit
|
11,250 |
| 2026-04-20 | Schmid John P. |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
9,200 |
| 2026-04-20 | Orwin John A |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | Schmid John P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
9,200 |
| 2026-04-20 | Schmid John P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
6,000 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
5,500 |
| 2026-04-20 | Schmid John P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
10,600 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
6,000 |
| 2026-04-20 | Schmid John P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
15,000 |
| 2026-04-20 | Faga Daniel |
Director, President, CEO |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The stock option is fully vested and exercisable. |
Employee Stock Option (right to buy)
|
11,000 |
| 2026-04-20 | Orwin John A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | Schmid John P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
10,600 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
6,000 |
| 2026-04-20 | Orwin John A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
10,600 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
11,000 |
| 2026-04-20 | Orwin John A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
8,250 |
| 2026-04-20 | Orwin John A |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | Schmid John P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
11,000 |
| 2026-04-20 | Schmid John P. |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
11,000 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
6,000 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
9,200 |
| 2026-04-20 | Schmid John P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
11,000 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | Schmid John P. |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
5,500 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
15,000 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
11,000 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | Schmid John P. |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
6,000 |
| 2026-04-20 | Schmid John P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
5,500 |
| 2026-04-20 | Orwin John A |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
10,600 |
| 2026-04-20 | Schmid John P. |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | Schmid John P. |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
11,000 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
6,000 |
| 2026-04-20 | Orwin John A |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
8,250 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
15,000 |
| 2026-04-20 | Orwin John A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
16,510 |
| 2026-04-20 | Schmid John P. |
Director |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
15,000 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
10,600 |
| 2026-04-20 | RENTON HOLLINGS |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
5,500 |